Records containing: Nonalcoholic Fatty Liver Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-08-27Screening of NASH in Oupatients Followed in Various Hospital Specialty Clinics at the University Hospital of Strasbourg
-
CLINICAL_TRIALS study record update · 2020-06-26Effects of High-Intensity Interval and Moderate Intensity Continuous Exercise on Diabetic Obese Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2020-04-30Evaluation of the Effects of a Low Free Sugar Diet on Lipid Profile, Glycemic Indices, Liver Enzymes, Inflammatory Factors and Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2020-04-13Laparoscopic Adjustable Gastric Banding (LAGB) as a Treatment for Morbid Obesity in Adolescents
-
CLINICAL_TRIALS study record update · 2020-03-19An Open-Label, Single-Dose, Fixed-Sequence Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986036 Administered to the Abdomen and Upper Arm in Healthy Participants
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-03-10A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, PARALLEL GROUP STUDY TO EVALUATE SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF PF-05221304 ADMINISTERED DAILY FOR 16-WEEKS TO ADULT SUBJECTS WITH NONALCOHOLIC FATTY LIVER DISEASE
-
CLINICAL_TRIALS study record update · 2020-02-21Effects of Fructose Restriction on Liver Steatosis
-
CLINICAL_TRIALS study record update · 2020-01-28Randomized, Controlled Dietary Treatment Study of Pediatric NAFLD
-
CLINICAL_TRIALS study record update · 2019-10-08A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986036 in Participants With Varying Degrees of Renal Function
-
CLINICAL_TRIALS study record update · 2019-08-21Aramchol Versus Placebo in the Treatment of HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy: A Randomized, Double-blinded, Allocation-concealed, Placebo-controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2019-07-05Association of Light-to-moderate Alcohol Consumption With Risk of Type 2 Diabetes Mellitus in Individuals With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2019-06-21Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese Population: a Cross-sectional Study
-
CLINICAL_TRIALS study record update · 2019-05-01Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis
-
CLINICAL_TRIALS study record update · 2018-08-06Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With Nonalcholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2017-12-29Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis
-
CLINICAL_TRIALS study record update · 2017-12-21A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, 12 Weeks, Therapeutic Exploratory Phase 2 Clinical Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Except Cirrhosis
-
CLINICAL_TRIALS study record update · 2017-12-19Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in Nonalcoholic Fatty Liver disease-a Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2017-11-01Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study
-
CLINICAL_TRIALS study record update · 2017-07-11Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
-
CLINICAL_TRIALS study record update · 2017-06-12The Impact of Autonomic Dysfunction on Liver-Related Symptoms in Non-Alcoholic Fatty Liver Disease and Their Relationship to Systemic Inflammation and Insulin Resistance
-
CLINICAL_TRIALS study record update · 2017-04-05Long-term Role of Pioglitazone in Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM).
-
CLINICAL_TRIALS study record update · 2017-03-27The Effect of High Fructose Corn Syrup Feeding in Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2017-02-08A Randomized Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection
-
CLINICAL_TRIALS study record update · 2017-01-10Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes
-
CLINICAL_TRIALS study record update · 2016-11-28The Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Utilizing Non-invasive Measures